Automated High Throughput Functional Cell-based Bioassays for EGFR Blocking Antibodies
11 July 2012

In this study, a novel, target-specific cell-based assay platform that can be used to detect and differentiate potential inhibitors of Epidermal Growth Factor receptors is described. The assay uses a full-length receptor protein and is based on a proprietary Enzyme Fragment Complementation (EFC) Assay Technology in a whole cell platform enabling antibody interrogation and characterization in a cellular context. The assay was automated in 384-well format, making it ideal for screening antibody clones.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!